SALUTARISMD BELIEVES IN SAVING VISION FOR ALL, REGARDLESS OF GEOGRAPHIC LOCATION
OR ECONOMIC STATUS.
Provide a cost-effective, accessible treatment for eye disease to those who:
• cannot benefit from current methods of treatment
• cannot afford current methods of treatment
• cannot access current methods of treatment
Patients with dark pigmented eyes tend to be non-responsive to anti-VEGF treatments
Many developing countries have large populations with dark pigmented eyes
The frequency, cost, and ineffectiveness of anti-VEGF treatments disproportionately impact the poorest populations around the world
SalutarisMD will set up a charitable foundation to promote physician-initiated studies of ophthalmic diseases using the BetaCurve by donating devices, training, and resources to provide care to underserved patients who would otherwise go untreated.
Current treatments for wet-AMD require frequent, often monthly, visits to a vitreoretinal surgeon to inject expensive anti-VEGF directly into the eye. Not only does this unpleasant procedure add to the existing suffering of people afflicted with the disease, the treatment burden and cost is too much to bear for those living in poverty.
Please join us in our efforts to save vision around the world.